Platform
Home
Screener
Copilot
AskEdgar Studio
New
Back
Septerna Inc
SEPN · SEC Filings
website
123
Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled rec...
Price
50.74
Market Cap
2.37 B
Float
19.55 M
Country
US
Sector
Healthcare
Exchange
NASDAQ
Overview
Filings
Insights
Dilution
News
Transcripts
Search in Documents
Open in Studio
Studio
Login
Ask about SEPN
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
All
Chronological
Financials
Registrations
Prospectus
News
Proxies
Ownerships
Other
Septerna Inc
SEPN · SEC Filings
19.55 M
Float
50.74
Price
2.37 B
Market Cap
Financials
TYPE
HEADLINE
FILED AT
10-Q
NEW
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 9, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 10, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 11, 2026
10-K
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 9, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 10, 2025
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 11, 2025
News
TYPE
HEADLINE
FILED AT
8-K
NEW
Septerna Reports Third Quarter 2026 Financial Results and Highlights Pipeline and Clinical Progress
Nov 9, 2026
8-K
Septerna Selects SEP-204 as Development Candidate for Graves’ Disease and TED and Reports Preclinical Data
Nov 4, 2026
8-K
Septerna Appoints Rajiv Patni, M.D., as Chief Medical Officer
Aug 25, 2026
8-K
Septerna Reports Second Quarter 2026 Financial Results and Pipeline Progress
Aug 10, 2026
8-K
Septerna, Inc. Announces Results of 2026 Annual Meeting of Stockholders
Jun 30, 2026
8-K
Septerna Highlights Pipeline Progress and Reports First Quarter 2026 Financial Results
May 11, 2026
Prospectus
TYPE
HEADLINE
FILED AT
424B4
OFFERING | Shares amount: 16,000,000 | Share price: $18.00 | Offering amount: $288,000,000.00
Oct 25, 2024
Registrations
TYPE
HEADLINE
FILED AT
S-3ASR
March 2026 SHELF + ATM
Mar 10, 2026
S-8
Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 9, 2026
S-8
Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 27, 2025
S-8
Form S-8 - Securities to be offered to employees in employee benefit plans
Oct 25, 2024
S-1MEF
INITIAL REGISTRATION FOR OFFERING | Shares amount: 830,556
Oct 24, 2024
S-1/A
INITIAL REGISTRATION FOR OFFERING | Shares amount: 15,277,778 | Share price: $18.00 EFFECTIVE
Oct 24, 2024
Proxies
TYPE
HEADLINE
FILED AT
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 30, 2026
DEF 14A
Form DEF 14A - Other definitive proxy statements
Apr 30, 2026
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 29, 2025
DEF 14A
Form DEF 14A - Other definitive proxy statements
Apr 29, 2025
Ownerships
TYPE
HEADLINE
FILED AT
4
Bhatt Elizabeth (Reporting)
Oct 19, 2026
144
Form 144 - Report of proposed sale of securities
Oct 1, 2026
144
Form 144 - Report of proposed sale of securities
Oct 1, 2026
4
Patni Rajiv (Reporting)
Sep 10, 2026
3
Patni Rajiv (Reporting)
Sep 3, 2026
4
Long Daniel D. (Reporting)
Sep 3, 2026
Chronological
TYPE
HEADLINE
FILED AT
Other
TYPE
HEADLINE
FILED AT
EFFECT
Form EFFECT - Notice of Effectiveness
Oct 25, 2024
CORRESP
Form CORRESP - Correspondence
Oct 22, 2024
CORRESP
Form CORRESP - Correspondence
Oct 22, 2024
CORRESP
Form CORRESP - Correspondence
Oct 15, 2024
CORRESP
Form CORRESP - Correspondence
Oct 2, 2024
LETTER
Form UPLOAD - SEC-generated letter
Sep 24, 2024
